glp 1 dose increase side effects GLP-1 Medications Infographic GLP-1RA Essentials in Gastroenterology: Side
Description
Mounjaro is FDA-approved to treat type 2 diabetes alongside diet and exercise
Patients with type 2 diabetes have an approximately two-fold risk for acute pancreatitis and a label indicating an acute pancreatitis risk has been added to all DPP-4 inhibitors
However, objective statistical analysis of the duration of T2DM between groups did not show any significant difference ( p = 0.23)
From a UTI perspective, this switch is neutral
